Related Experiment Video
Updated: Jul 18, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Individualized pharmacogenetic therapy: a critical analysis
Mechtild Schmedders1, Jan van Aken, Günter Feuerstein
1Forschungsschwerpunkt Biotechnik, Gesellschaft, Umwelt, Universität Hamburg, Hamburg, Deutschland. Mechtild.Schmedders@Uni-Hamburg.de
Pharmacogenetics aims for individualized therapy, but its current biomechanistic approach leads to patient stratification rather than true personalization. The concept of "individualization" in pharmacogenetics is a theoretically unjustified slogan.
Area of Science:
- Pharmacogenetics
- Genomics
- Personalized Medicine
Background:
- Pharmacogenetics is often presented as a tool for achieving individualized therapy.
- The concept of individualization is central to the stated goals of pharmacogenetics.
Purpose of the Study:
- To analyze the content and significance of the concept of individualization in pharmacogenetics.
- To critically evaluate the ideological underpinnings of pharmacogenetic approaches to therapy.
Main Methods:
- Systematic literature review of current pharmacogenetics research.
- Conceptual analysis of the term 'individualization' within the field.
Main Results:
- Pharmacogenetic individualization relies on a biomechanistic paradigm.
- This paradigm results in patient population stratification and classification, not psychosocial individualization.
- The efficacy of pharmacogenetics is not questioned, but its underlying ideology is.
Conclusions:
- The term 'individualization of therapy' is a publicity slogan, not a reflection of pharmacogenetics' true potential.
- The current understanding of individualization in pharmacogenetics is theoretically unjustified.
- Pharmacogenetics primarily stratifies patients rather than offering true individual-tailored therapy.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Related Concept Videos
Dosage Regimen: Individualization
Pharmacogenetics and Pharmacogenomics: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets